aluates Reports

$ 0.0

Automative

Global Medications for Alcohol Use Disorder (AUD) Market Research Report 2024

Published Date: September 2024

Report Code: QYRE-Auto-18H18245

BUY CHAPTERS

Global Medications for Alcohol Use Disorder (AUD) Market Research Report 2024

Code: QYRE-Auto-18H18245

Report

September 2024

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Alkermes plc

Merck KGaA

Lundbeck

Alvogen

Mylan NV

TEVA

Sun Pharmaceutical Industries

Zydus Pharmaceuticals

Taj Pharmaceuticals

TAGI Pharma Inc.

Beijing Wellso Pharmaceutical Co

Glenmark Pharmaceuticals

Rusan Pharma Ltd.

Medications for Alcohol Use Disorder (AUD) Market

Alcohol use disorder (AUD), is a chronic condition characterized by an inability to control alcohol consumption despite negative consequences. It involves a physical and psychological dependence on alcohol, where individuals may experience cravings, withdrawal symptoms, and a persistent desire to drink. Medications for Alcohol Use Disorder (AUD) are an important component of treatment, helping individuals manage cravings, reduce alcohol consumption, and maintain sobriety. Currently, commonly used drugs include naltrexone, acamprosate, etc.

The global Medications for Alcohol Use Disorder (AUD) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Medications for Alcohol Use Disorder (AUD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Medications for Alcohol Use Disorder (AUD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Medications for Alcohol Use Disorder (AUD) in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Medications for Alcohol Use Disorder (AUD) include Alkermes, Merck KGaA, Lundbeck, Alvogen, Mylan, Teva, Sun Pharmaceutical Industries, Zydus Pharmaceuticals, Taj Pharmaceuticals, TAGI Pharma Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Medications for Alcohol Use Disorder (AUD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medications for Alcohol Use Disorder (AUD).

The Medications for Alcohol Use Disorder (AUD) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medications for Alcohol Use Disorder (AUD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Medications for Alcohol Use Disorder (AUD) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Medications for Alcohol Use Disorder (AUD) Market Report

Report Metric	Details
Report Name	Medications for Alcohol Use Disorder (AUD) Market
Segment by Type	Naltrexone Acamprosate Disulfiram Other
Segment by Application	Hospital Rehabilitation Institutions Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alkermes, Merck KGaA, Lundbeck, Alvogen, Mylan, Teva, Sun Pharmaceutical Industries, Zydus Pharmaceuticals, Taj Pharmaceuticals, TAGI Pharma Inc., Beijing Wellso Pharmaceutical Co, Glenmark Pharmaceuticals, Rusan Pharma Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medications for Alcohol Use Disorder (AUD) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Medications for Alcohol Use Disorder (AUD) Market report?

Ans: The main players in the Medications for Alcohol Use Disorder (AUD) Market are Alkermes, Merck KGaA, Lundbeck, Alvogen, Mylan, Teva, Sun Pharmaceutical Industries, Zydus Pharmaceuticals, Taj Pharmaceuticals, TAGI Pharma Inc., Beijing Wellso Pharmaceutical Co, Glenmark Pharmaceuticals, Rusan Pharma Ltd

What are the Application segmentation covered in the Medications for Alcohol Use Disorder (AUD) Market report?

Ans: The Applications covered in the Medications for Alcohol Use Disorder (AUD) Market report are Hospital, Rehabilitation Institutions, Others

What are the Type segmentation covered in the Medications for Alcohol Use Disorder (AUD) Market report?

Ans: The Types covered in the Medications for Alcohol Use Disorder (AUD) Market report are Naltrexone, Acamprosate, Disulfiram, Other

Recommended Reports

Alcohol Related Markets

Addiction & Mental Health

Disorder Drug Treatments

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Naltrexone

1.2.3 Acamprosate

1.2.4 Disulfiram

1.2.5 Other

1.3 Market by Application

1.3.1 Global Medications for Alcohol Use Disorder (AUD) Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Rehabilitation Institutions

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Medications for Alcohol Use Disorder (AUD) Market Perspective (2019-2030)

2.2 Global Medications for Alcohol Use Disorder (AUD) Growth Trends by Region

2.2.1 Global Medications for Alcohol Use Disorder (AUD) Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Medications for Alcohol Use Disorder (AUD) Historic Market Size by Region (2019-2024)

2.2.3 Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Region (2025-2030)

2.3 Medications for Alcohol Use Disorder (AUD) Market Dynamics

2.3.1 Medications for Alcohol Use Disorder (AUD) Industry Trends

2.3.2 Medications for Alcohol Use Disorder (AUD) Market Drivers

2.3.3 Medications for Alcohol Use Disorder (AUD) Market Challenges

2.3.4 Medications for Alcohol Use Disorder (AUD) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Medications for Alcohol Use Disorder (AUD) Players by Revenue

3.1.1 Global Top Medications for Alcohol Use Disorder (AUD) Players by Revenue (2019-2024)

3.1.2 Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Players (2019-2024)

3.2 Global Medications for Alcohol Use Disorder (AUD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Medications for Alcohol Use Disorder (AUD) Revenue

3.4 Global Medications for Alcohol Use Disorder (AUD) Market Concentration Ratio

3.4.1 Global Medications for Alcohol Use Disorder (AUD) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Medications for Alcohol Use Disorder (AUD) Revenue in 2023

3.5 Global Key Players of Medications for Alcohol Use Disorder (AUD) Head office and Area Served

3.6 Global Key Players of Medications for Alcohol Use Disorder (AUD), Product and Application

3.7 Global Key Players of Medications for Alcohol Use Disorder (AUD), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Medications for Alcohol Use Disorder (AUD) Breakdown Data by Type

4.1 Global Medications for Alcohol Use Disorder (AUD) Historic Market Size by Type (2019-2024)

4.2 Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Type (2025-2030)

5 Medications for Alcohol Use Disorder (AUD) Breakdown Data by Application

5.1 Global Medications for Alcohol Use Disorder (AUD) Historic Market Size by Application (2019-2024)

5.2 Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Medications for Alcohol Use Disorder (AUD) Market Size (2019-2030)

6.2 North America Medications for Alcohol Use Disorder (AUD) Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2019-2024)

6.4 North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Medications for Alcohol Use Disorder (AUD) Market Size (2019-2030)

7.2 Europe Medications for Alcohol Use Disorder (AUD) Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2019-2024)

7.4 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size (2019-2030)

8.2 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size by Region (2019-2024)

8.4 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Medications for Alcohol Use Disorder (AUD) Market Size (2019-2030)

9.2 Latin America Medications for Alcohol Use Disorder (AUD) Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2019-2024)

9.4 Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size (2019-2030)

10.2 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (2019-2024)

10.4 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Alkermes

11.1.1 Alkermes Company Details

11.1.2 Alkermes Business Overview

11.1.3 Alkermes Medications for Alcohol Use Disorder (AUD) Introduction

11.1.4 Alkermes Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

11.1.5 Alkermes Recent Development

11.2 Merck KGaA

11.2.1 Merck KGaA Company Details

11.2.2 Merck KGaA Business Overview

11.2.3 Merck KGaA Medications for Alcohol Use Disorder (AUD) Introduction

11.2.4 Merck KGaA Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

11.2.5 Merck KGaA Recent Development

11.3 Lundbeck

11.3.1 Lundbeck Company Details

11.3.2 Lundbeck Business Overview

11.3.3 Lundbeck Medications for Alcohol Use Disorder (AUD) Introduction

11.3.4 Lundbeck Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

11.3.5 Lundbeck Recent Development

11.4 Alvogen

11.4.1 Alvogen Company Details

11.4.2 Alvogen Business Overview

11.4.3 Alvogen Medications for Alcohol Use Disorder (AUD) Introduction

11.4.4 Alvogen Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

11.4.5 Alvogen Recent Development

11.5 Mylan

11.5.1 Mylan Company Details

11.5.2 Mylan Business Overview

11.5.3 Mylan Medications for Alcohol Use Disorder (AUD) Introduction

11.5.4 Mylan Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

11.5.5 Mylan Recent Development

11.6 Teva

11.6.1 Teva Company Details

11.6.2 Teva Business Overview

11.6.3 Teva Medications for Alcohol Use Disorder (AUD) Introduction

11.6.4 Teva Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

11.6.5 Teva Recent Development

11.7 Sun Pharmaceutical Industries

11.7.1 Sun Pharmaceutical Industries Company Details

11.7.2 Sun Pharmaceutical Industries Business Overview

11.7.3 Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Introduction

11.7.4 Sun Pharmaceutical Industries Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

11.7.5 Sun Pharmaceutical Industries Recent Development

11.8 Zydus Pharmaceuticals

11.8.1 Zydus Pharmaceuticals Company Details

11.8.2 Zydus Pharmaceuticals Business Overview

11.8.3 Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Introduction

11.8.4 Zydus Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

11.8.5 Zydus Pharmaceuticals Recent Development

11.9 Taj Pharmaceuticals

11.9.1 Taj Pharmaceuticals Company Details

11.9.2 Taj Pharmaceuticals Business Overview

11.9.3 Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Introduction

11.9.4 Taj Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

11.9.5 Taj Pharmaceuticals Recent Development

11.10 TAGI Pharma Inc.

11.10.1 TAGI Pharma Inc. Company Details

11.10.2 TAGI Pharma Inc. Business Overview

11.10.3 TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Introduction

11.10.4 TAGI Pharma Inc. Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

11.10.5 TAGI Pharma Inc. Recent Development

11.11 Beijing Wellso Pharmaceutical Co

11.11.1 Beijing Wellso Pharmaceutical Co Company Details

11.11.2 Beijing Wellso Pharmaceutical Co Business Overview

11.11.3 Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Introduction

11.11.4 Beijing Wellso Pharmaceutical Co Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

11.11.5 Beijing Wellso Pharmaceutical Co Recent Development

11.12 Glenmark Pharmaceuticals

11.12.1 Glenmark Pharmaceuticals Company Details

11.12.2 Glenmark Pharmaceuticals Business Overview

11.12.3 Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Introduction

11.12.4 Glenmark Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

11.12.5 Glenmark Pharmaceuticals Recent Development

11.13 Rusan Pharma Ltd

11.13.1 Rusan Pharma Ltd Company Details

11.13.2 Rusan Pharma Ltd Business Overview

11.13.3 Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Introduction

11.13.4 Rusan Pharma Ltd Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

11.13.5 Rusan Pharma Ltd Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Alkermes plc

Merck KGaA

Lundbeck

Alvogen

Mylan NV

TEVA

Sun Pharmaceutical Industries

Zydus Pharmaceuticals

Taj Pharmaceuticals

TAGI Pharma Inc.

Beijing Wellso Pharmaceutical Co

Glenmark Pharmaceuticals

Rusan Pharma Ltd.

List of Tables

Table 1. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Naltrexone

Table 3. Key Players of Acamprosate

Table 4. Key Players of Disulfiram

Table 5. Key Players of Other

Table 6. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Medications for Alcohol Use Disorder (AUD) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Medications for Alcohol Use Disorder (AUD) Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region (2019-2024)

Table 10. Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region (2025-2030)

Table 12. Medications for Alcohol Use Disorder (AUD) Market Trends

Table 13. Medications for Alcohol Use Disorder (AUD) Market Drivers

Table 14. Medications for Alcohol Use Disorder (AUD) Market Challenges

Table 15. Medications for Alcohol Use Disorder (AUD) Market Restraints

Table 16. Global Medications for Alcohol Use Disorder (AUD) Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Medications for Alcohol Use Disorder (AUD) Market Share by Players (2019-2024)

Table 18. Global Top Medications for Alcohol Use Disorder (AUD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medications for Alcohol Use Disorder (AUD) as of 2023)

Table 19. Ranking of Global Top Medications for Alcohol Use Disorder (AUD) Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Medications for Alcohol Use Disorder (AUD) Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Medications for Alcohol Use Disorder (AUD), Headquarters and Area Served

Table 22. Global Key Players of Medications for Alcohol Use Disorder (AUD), Product and Application

Table 23. Global Key Players of Medications for Alcohol Use Disorder (AUD), Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Medications for Alcohol Use Disorder (AUD) Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Type (2019-2024)

Table 27. Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Type (2025-2030)

Table 29. Global Medications for Alcohol Use Disorder (AUD) Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Application (2019-2024)

Table 31. Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Application (2025-2030)

Table 33. North America Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (2025-2030) & (US$ Million)

Table 48. Alkermes Company Details

Table 49. Alkermes Business Overview

Table 50. Alkermes Medications for Alcohol Use Disorder (AUD) Product

Table 51. Alkermes Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 52. Alkermes Recent Development

Table 53. Merck KGaA Company Details

Table 54. Merck KGaA Business Overview

Table 55. Merck KGaA Medications for Alcohol Use Disorder (AUD) Product

Table 56. Merck KGaA Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 57. Merck KGaA Recent Development

Table 58. Lundbeck Company Details

Table 59. Lundbeck Business Overview

Table 60. Lundbeck Medications for Alcohol Use Disorder (AUD) Product

Table 61. Lundbeck Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 62. Lundbeck Recent Development

Table 63. Alvogen Company Details

Table 64. Alvogen Business Overview

Table 65. Alvogen Medications for Alcohol Use Disorder (AUD) Product

Table 66. Alvogen Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 67. Alvogen Recent Development

Table 68. Mylan Company Details

Table 69. Mylan Business Overview

Table 70. Mylan Medications for Alcohol Use Disorder (AUD) Product

Table 71. Mylan Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 72. Mylan Recent Development

Table 73. Teva Company Details

Table 74. Teva Business Overview

Table 75. Teva Medications for Alcohol Use Disorder (AUD) Product

Table 76. Teva Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 77. Teva Recent Development

Table 78. Sun Pharmaceutical Industries Company Details

Table 79. Sun Pharmaceutical Industries Business Overview

Table 80. Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Product

Table 81. Sun Pharmaceutical Industries Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 82. Sun Pharmaceutical Industries Recent Development

Table 83. Zydus Pharmaceuticals Company Details

Table 84. Zydus Pharmaceuticals Business Overview

Table 85. Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product

Table 86. Zydus Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 87. Zydus Pharmaceuticals Recent Development

Table 88. Taj Pharmaceuticals Company Details

Table 89. Taj Pharmaceuticals Business Overview

Table 90. Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product

Table 91. Taj Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 92. Taj Pharmaceuticals Recent Development

Table 93. TAGI Pharma Inc. Company Details

Table 94. TAGI Pharma Inc. Business Overview

Table 95. TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Product

Table 96. TAGI Pharma Inc. Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 97. TAGI Pharma Inc. Recent Development

Table 98. Beijing Wellso Pharmaceutical Co Company Details

Table 99. Beijing Wellso Pharmaceutical Co Business Overview

Table 100. Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Product

Table 101. Beijing Wellso Pharmaceutical Co Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 102. Beijing Wellso Pharmaceutical Co Recent Development

Table 103. Glenmark Pharmaceuticals Company Details

Table 104. Glenmark Pharmaceuticals Business Overview

Table 105. Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product

Table 106. Glenmark Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 107. Glenmark Pharmaceuticals Recent Development

Table 108. Rusan Pharma Ltd Company Details

Table 109. Rusan Pharma Ltd Business Overview

Table 110. Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Product

Table 111. Rusan Pharma Ltd Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 112. Rusan Pharma Ltd Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Medications for Alcohol Use Disorder (AUD) Picture

Figure 2. Global Medications for Alcohol Use Disorder (AUD) Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Medications for Alcohol Use Disorder (AUD) Market Share by Type: 2023 VS 2030

Figure 4. Naltrexone Features

Figure 5. Acamprosate Features

Figure 6. Disulfiram Features

Figure 7. Other Features

Figure 8. Global Medications for Alcohol Use Disorder (AUD) Market Size by Application (2024-2030) & (US$ Million)

Figure 9. Global Medications for Alcohol Use Disorder (AUD) Market Share by Application: 2023 VS 2030

Figure 10. Hospital Case Studies

Figure 11. Rehabilitation Institutions Case Studies

Figure 12. Others Case Studies

Figure 13. Medications for Alcohol Use Disorder (AUD) Report Years Considered

Figure 14. Global Medications for Alcohol Use Disorder (AUD) Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Medications for Alcohol Use Disorder (AUD) Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region: 2023 VS 2030

Figure 17. Global Medications for Alcohol Use Disorder (AUD) Market Share by Players in 2023

Figure 18. Global Top Medications for Alcohol Use Disorder (AUD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medications for Alcohol Use Disorder (AUD) as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Medications for Alcohol Use Disorder (AUD) Revenue in 2023

Figure 20. North America Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Medications for Alcohol Use Disorder (AUD) Market Share by Country (2019-2030)

Figure 22. United States Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Medications for Alcohol Use Disorder (AUD) Market Share by Country (2019-2030)

Figure 26. Germany Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Share by Region (2019-2030)

Figure 34. China Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Medications for Alcohol Use Disorder (AUD) Market Share by Country (2019-2030)

Figure 42. Mexico Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Share by Country (2019-2030)

Figure 46. Turkey Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. UAE Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Alkermes Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 50. Merck KGaA Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 51. Lundbeck Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 52. Alvogen Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 53. Mylan Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 54. Teva Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 55. Sun Pharmaceutical Industries Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 56. Zydus Pharmaceuticals Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 57. Taj Pharmaceuticals Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 58. TAGI Pharma Inc. Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 59. Beijing Wellso Pharmaceutical Co Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 60. Glenmark Pharmaceuticals Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 61. Rusan Pharma Ltd Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Alcohol Addiction Treatments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alcoholism Treatment Market Research Report 2024

Substance Use Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medications for Treating Alcohol Dependence Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Abuse Treatment Market Insights Forecast to 2030

Global Alcohol Treatment Services Market Research Report 2024

Substance Abuse and Addiction Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Substance Abuse Therapeutics Market Insights Forecast to 2030

Global Alcohol and Drug Services Market Research Report 2024

Global Opioid Use Disorder Market Insights Forecast to 2030

Global Naltrexone HCL Market Research Report 2025

Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global ADHD Drug Treatment Market Research Report 2024

Global Alcoholic Hepatitis Treatment Market Insights Forecast to 2030

Global Alcohol Dependency Treatment Market Research Report 2025

Global Addictions Therapeutics Market Insights Forecast to 2030

Global Attention deficit Hyperactivity Disorder ADHD Therapeutics Market Research Report 2024

Global Naltrexone Hydrochloride Market Research Report 2025

Global Adult Attention Deficit and Hyperactivity Disorder Market Research Report 2025

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions